nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—Estrogen Receptor Agonists—Ethinyl Estradiol—prostate cancer	0.14	0.569	CiPCiCtD
Conjugated Estrogens—Estrogen Receptor Agonists—Estradiol—prostate cancer	0.106	0.431	CiPCiCtD
Conjugated Estrogens—Estramustine—prostate cancer	0.07	0.335	CrCtD
Conjugated Estrogens—Estrone—prostate cancer	0.0556	0.266	CrCtD
Conjugated Estrogens—Estradiol—prostate cancer	0.0422	0.202	CrCtD
Conjugated Estrogens—Ethinyl Estradiol—prostate cancer	0.0412	0.197	CrCtD
Conjugated Estrogens—breast cancer—Estrone—prostate cancer	0.0399	0.3	CpDpCtD
Conjugated Estrogens—breast cancer—Estradiol valerate/Dienogest—prostate cancer	0.0399	0.3	CpDpCtD
Conjugated Estrogens—breast cancer—Estradiol—prostate cancer	0.0302	0.227	CpDpCtD
Conjugated Estrogens—COMT—prostate cancer	0.0261	0.357	CbGaD
Conjugated Estrogens—ESR2—prostate cancer	0.0243	0.333	CbGaD
Conjugated Estrogens—breast cancer—Ethinyl Estradiol—prostate cancer	0.0229	0.172	CpDpCtD
Conjugated Estrogens—ESR1—prostate cancer	0.015	0.205	CbGaD
Conjugated Estrogens—ESR2—Estramustine—prostate cancer	0.0114	0.0909	CbGbCtD
Conjugated Estrogens—CYP3A4—prostate cancer	0.00764	0.105	CbGaD
Conjugated Estrogens—ESR2—Estrone—prostate cancer	0.00735	0.0586	CbGbCtD
Conjugated Estrogens—SLC10A1—Ethinyl Estradiol—prostate cancer	0.00698	0.0557	CbGbCtD
Conjugated Estrogens—ESR2—Ethinyl Estradiol—prostate cancer	0.00655	0.0522	CbGbCtD
Conjugated Estrogens—Estriol—Estramustine—prostate cancer	0.00651	0.0464	CrCrCtD
Conjugated Estrogens—Equilin—Estrone—prostate cancer	0.00633	0.0451	CrCrCtD
Conjugated Estrogens—ESR1—Estramustine—prostate cancer	0.00584	0.0466	CbGbCtD
Conjugated Estrogens—SLCO4A1—Estradiol—prostate cancer	0.00566	0.0451	CbGbCtD
Conjugated Estrogens—Estropipate—Estramustine—prostate cancer	0.00555	0.0395	CrCrCtD
Conjugated Estrogens—Estriol—Estrone—prostate cancer	0.00518	0.0369	CrCrCtD
Conjugated Estrogens—Estramustine—Estrone—prostate cancer	0.00518	0.0369	CrCrCtD
Conjugated Estrogens—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.00484	0.0345	CrCrCtD
Conjugated Estrogens—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00484	0.0345	CrCrCtD
Conjugated Estrogens—Equilin—Estradiol—prostate cancer	0.0048	0.0342	CrCrCtD
Conjugated Estrogens—Equilin—Ethinyl Estradiol—prostate cancer	0.00468	0.0333	CrCrCtD
Conjugated Estrogens—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00461	0.0328	CrCrCtD
Conjugated Estrogens—Estropipate—Estrone—prostate cancer	0.00441	0.0314	CrCrCtD
Conjugated Estrogens—SLCO2B1—Estrone—prostate cancer	0.00436	0.0347	CbGbCtD
Conjugated Estrogens—ESR2—Estradiol—prostate cancer	0.00422	0.0336	CbGbCtD
Conjugated Estrogens—Quinestrol—Estramustine—prostate cancer	0.00411	0.0293	CrCrCtD
Conjugated Estrogens—Mestranol—Estramustine—prostate cancer	0.00411	0.0293	CrCrCtD
Conjugated Estrogens—Estradiol—Estramustine—prostate cancer	0.00411	0.0293	CrCrCtD
Conjugated Estrogens—Estrone—Estramustine—prostate cancer	0.00411	0.0293	CrCrCtD
Conjugated Estrogens—Exemestane—Estrone—prostate cancer	0.00411	0.0293	CrCrCtD
Conjugated Estrogens—SLCO1C1—Estradiol—prostate cancer	0.00398	0.0317	CbGbCtD
Conjugated Estrogens—SLCO1B3—Cabazitaxel—prostate cancer	0.00396	0.0315	CbGbCtD
Conjugated Estrogens—Estriol—Estradiol—prostate cancer	0.00392	0.0279	CrCrCtD
Conjugated Estrogens—Estramustine—Estradiol—prostate cancer	0.00392	0.0279	CrCrCtD
Conjugated Estrogens—Ethinyl Estradiol—Estramustine—prostate cancer	0.00392	0.0279	CrCrCtD
Conjugated Estrogens—Estramustine—Ethinyl Estradiol—prostate cancer	0.00383	0.0273	CrCrCtD
Conjugated Estrogens—Estriol—Ethinyl Estradiol—prostate cancer	0.00383	0.0273	CrCrCtD
Conjugated Estrogens—ESR1—Estrone—prostate cancer	0.00376	0.03	CbGbCtD
Conjugated Estrogens—ABCC1—Abiraterone—prostate cancer	0.0037	0.0295	CbGbCtD
Conjugated Estrogens—Formestane—Estrone—prostate cancer	0.00344	0.0245	CrCrCtD
Conjugated Estrogens—ESR1—Ethinyl Estradiol—prostate cancer	0.00336	0.0267	CbGbCtD
Conjugated Estrogens—Estropipate—Estradiol—prostate cancer	0.00334	0.0238	CrCrCtD
Conjugated Estrogens—Estradiol—Estrone—prostate cancer	0.00327	0.0233	CrCrCtD
Conjugated Estrogens—Quinestrol—Estrone—prostate cancer	0.00327	0.0233	CrCrCtD
Conjugated Estrogens—Mestranol—Estrone—prostate cancer	0.00327	0.0233	CrCrCtD
Conjugated Estrogens—Estropipate—Ethinyl Estradiol—prostate cancer	0.00326	0.0232	CrCrCtD
Conjugated Estrogens—Ethinyl Estradiol—Estrone—prostate cancer	0.00311	0.0222	CrCrCtD
Conjugated Estrogens—SLCO2B1—Estradiol—prostate cancer	0.0025	0.0199	CbGbCtD
Conjugated Estrogens—Estrone—Estradiol—prostate cancer	0.00248	0.0176	CrCrCtD
Conjugated Estrogens—Mestranol—Estradiol—prostate cancer	0.00248	0.0176	CrCrCtD
Conjugated Estrogens—Quinestrol—Estradiol—prostate cancer	0.00248	0.0176	CrCrCtD
Conjugated Estrogens—Estradiol—Ethinyl Estradiol—prostate cancer	0.00242	0.0172	CrCrCtD
Conjugated Estrogens—Quinestrol—Ethinyl Estradiol—prostate cancer	0.00242	0.0172	CrCrCtD
Conjugated Estrogens—Estrone—Ethinyl Estradiol—prostate cancer	0.00242	0.0172	CrCrCtD
Conjugated Estrogens—Mestranol—Ethinyl Estradiol—prostate cancer	0.00242	0.0172	CrCrCtD
Conjugated Estrogens—SLCO1A2—Estrone—prostate cancer	0.00239	0.019	CbGbCtD
Conjugated Estrogens—Ethinyl Estradiol—Estradiol—prostate cancer	0.00236	0.0168	CrCrCtD
Conjugated Estrogens—SLCO1B1—Cabazitaxel—prostate cancer	0.0023	0.0184	CbGbCtD
Conjugated Estrogens—SLCO1B1—Estrone—prostate cancer	0.00225	0.018	CbGbCtD
Conjugated Estrogens—SLCO1B3—Estradiol—prostate cancer	0.00222	0.0177	CbGbCtD
Conjugated Estrogens—ESR1—Estradiol—prostate cancer	0.00216	0.0172	CbGbCtD
Conjugated Estrogens—SLC22A11—Estradiol—prostate cancer	0.00205	0.0164	CbGbCtD
Conjugated Estrogens—ABCG2—Cabazitaxel—prostate cancer	0.00183	0.0146	CbGbCtD
Conjugated Estrogens—ABCG2—Estrone—prostate cancer	0.00179	0.0143	CbGbCtD
Conjugated Estrogens—ABCC2—Ethinyl Estradiol—prostate cancer	0.00176	0.0141	CbGbCtD
Conjugated Estrogens—ABCC3—Etoposide—prostate cancer	0.00163	0.013	CbGbCtD
Conjugated Estrogens—ABCC1—Mitoxantrone—prostate cancer	0.00159	0.0127	CbGbCtD
Conjugated Estrogens—SLCO1A2—Estradiol—prostate cancer	0.00137	0.0109	CbGbCtD
Conjugated Estrogens—SLCO1B3—Docetaxel—prostate cancer	0.00133	0.0106	CbGbCtD
Conjugated Estrogens—SLCO1B1—Estradiol—prostate cancer	0.00129	0.0103	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—prostate cancer	0.00129	0.0103	CbGbCtD
Conjugated Estrogens—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00123	0.00979	CbGbCtD
Conjugated Estrogens—SLC22A8—Estradiol—prostate cancer	0.00119	0.00952	CbGbCtD
Conjugated Estrogens—SLCO1A2—Prednisone—prostate cancer	0.00118	0.0094	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—prostate cancer	0.00111	0.00888	CbGbCtD
Conjugated Estrogens—Exemestane—Prednisone—prostate cancer	0.00107	0.00761	CrCrCtD
Conjugated Estrogens—ABCG2—Mitoxantrone—prostate cancer	0.00106	0.00848	CbGbCtD
Conjugated Estrogens—ABCG2—Estradiol—prostate cancer	0.00103	0.00819	CbGbCtD
Conjugated Estrogens—CYP1A2—Flutamide—prostate cancer	0.00102	0.00813	CbGbCtD
Conjugated Estrogens—ABCC1—Etoposide—prostate cancer	0.001	0.00799	CbGbCtD
Conjugated Estrogens—ABCB1—Estramustine—prostate cancer	0.001	0.00798	CbGbCtD
Conjugated Estrogens—ABCC1—Docetaxel—prostate cancer	0.000918	0.00731	CbGbCtD
Conjugated Estrogens—ABCC2—Etoposide—prostate cancer	0.000742	0.00592	CbGbCtD
Conjugated Estrogens—CYP1A2—Estrone—prostate cancer	0.000738	0.00588	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—prostate cancer	0.000684	0.00545	CbGbCtD
Conjugated Estrogens—ABCC2—Docetaxel—prostate cancer	0.000679	0.00541	CbGbCtD
Conjugated Estrogens—ABCG2—Etoposide—prostate cancer	0.000671	0.00535	CbGbCtD
Conjugated Estrogens—ABCB1—Cabazitaxel—prostate cancer	0.00066	0.00526	CbGbCtD
Conjugated Estrogens—CYP3A4—Bicalutamide—prostate cancer	0.000645	0.00514	CbGbCtD
Conjugated Estrogens—ABCB1—Estrone—prostate cancer	0.000645	0.00514	CbGbCtD
Conjugated Estrogens—ABCG2—Docetaxel—prostate cancer	0.000614	0.00489	CbGbCtD
Conjugated Estrogens—CYP3A4—Estramustine—prostate cancer	0.0006	0.00478	CbGbCtD
Conjugated Estrogens—ABCB1—Ethinyl Estradiol—prostate cancer	0.000575	0.00458	CbGbCtD
Conjugated Estrogens—SLC51B—prostate gland—prostate cancer	0.000537	0.0548	CbGeAlD
Conjugated Estrogens—CYP3A4—Flutamide—prostate cancer	0.000535	0.00426	CbGbCtD
Conjugated Estrogens—CYP3A4—Abiraterone—prostate cancer	0.000535	0.00426	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—prostate cancer	0.000506	0.00403	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—prostate cancer	0.000458	0.00365	CbGbCtD
Conjugated Estrogens—CYP1A2—Estradiol—prostate cancer	0.000424	0.00338	CbGbCtD
Conjugated Estrogens—CYP3A4—Cabazitaxel—prostate cancer	0.000396	0.00315	CbGbCtD
Conjugated Estrogens—CYP3A4—Estrone—prostate cancer	0.000387	0.00308	CbGbCtD
Conjugated Estrogens—SLC51A—prostate gland—prostate cancer	0.000385	0.0393	CbGeAlD
Conjugated Estrogens—ABCB1—Mitoxantrone—prostate cancer	0.000384	0.00306	CbGbCtD
Conjugated Estrogens—Equilin—HSD17B1—prostate cancer	0.000376	0.356	CrCbGaD
Conjugated Estrogens—ABCB1—Estradiol—prostate cancer	0.000371	0.00295	CbGbCtD
Conjugated Estrogens—SLC22A8—urine—prostate cancer	0.000358	0.0365	CbGeAlD
Conjugated Estrogens—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000345	0.00275	CbGbCtD
Conjugated Estrogens—ABCB1—Prednisone—prostate cancer	0.000319	0.00254	CbGbCtD
Conjugated Estrogens—CYP1A2—Etoposide—prostate cancer	0.000277	0.00221	CbGbCtD
Conjugated Estrogens—SLC10A1—prostate gland—prostate cancer	0.00025	0.0255	CbGeAlD
Conjugated Estrogens—CYP1A2—urine—prostate cancer	0.000245	0.025	CbGeAlD
Conjugated Estrogens—ABCB1—Etoposide—prostate cancer	0.000242	0.00193	CbGbCtD
Conjugated Estrogens—SLC51B—testis—prostate cancer	0.000237	0.0242	CbGeAlD
Conjugated Estrogens—CYP3A4—Mitoxantrone—prostate cancer	0.00023	0.00183	CbGbCtD
Conjugated Estrogens—CYP3A4—Estradiol—prostate cancer	0.000222	0.00177	CbGbCtD
Conjugated Estrogens—ABCB1—Docetaxel—prostate cancer	0.000221	0.00176	CbGbCtD
Conjugated Estrogens—SLC10A1—seminal vesicle—prostate cancer	0.000211	0.0215	CbGeAlD
Conjugated Estrogens—ABCC11—testis—prostate cancer	0.000211	0.0215	CbGeAlD
Conjugated Estrogens—SLCO3A1—prostate gland—prostate cancer	0.000206	0.0211	CbGeAlD
Conjugated Estrogens—CYP3A4—Prednisone—prostate cancer	0.000191	0.00152	CbGbCtD
Conjugated Estrogens—SLCO4A1—prostate gland—prostate cancer	0.000188	0.0192	CbGeAlD
Conjugated Estrogens—CYP3A4—urine—prostate cancer	0.000177	0.0181	CbGeAlD
Conjugated Estrogens—SLCO3A1—seminal vesicle—prostate cancer	0.000175	0.0178	CbGeAlD
Conjugated Estrogens—SLC10A1—renal system—prostate cancer	0.00017	0.0174	CbGeAlD
Conjugated Estrogens—SLC51A—testis—prostate cancer	0.00017	0.0173	CbGeAlD
Conjugated Estrogens—ESR2—prostate gland—prostate cancer	0.000167	0.017	CbGeAlD
Conjugated Estrogens—ABCB1—Doxorubicin—prostate cancer	0.000165	0.00132	CbGbCtD
Conjugated Estrogens—SLCO1C1—renal system—prostate cancer	0.00016	0.0163	CbGeAlD
Conjugated Estrogens—SLCO4A1—seminal vesicle—prostate cancer	0.000159	0.0162	CbGeAlD
Conjugated Estrogens—COMT—prostate gland—prostate cancer	0.000159	0.0162	CbGeAlD
Conjugated Estrogens—ABCC3—prostate gland—prostate cancer	0.000157	0.016	CbGeAlD
Conjugated Estrogens—SLC22A11—renal system—prostate cancer	0.000155	0.0159	CbGeAlD
Conjugated Estrogens—SLCO2B1—prostate gland—prostate cancer	0.000146	0.0149	CbGeAlD
Conjugated Estrogens—CYP3A4—Etoposide—prostate cancer	0.000145	0.00116	CbGbCtD
Conjugated Estrogens—SLCO3A1—renal system—prostate cancer	0.000141	0.0144	CbGeAlD
Conjugated Estrogens—SLCO3A1—urethra—prostate cancer	0.000138	0.0141	CbGeAlD
Conjugated Estrogens—COMT—seminal vesicle—prostate cancer	0.000134	0.0137	CbGeAlD
Conjugated Estrogens—CYP3A4—Docetaxel—prostate cancer	0.000133	0.00106	CbGbCtD
Conjugated Estrogens—ABCC4—prostate gland—prostate cancer	0.00013	0.0132	CbGeAlD
Conjugated Estrogens—SLC22A8—prostate gland—prostate cancer	0.000129	0.0131	CbGeAlD
Conjugated Estrogens—SLCO4A1—renal system—prostate cancer	0.000128	0.0131	CbGeAlD
Conjugated Estrogens—SLCO4A1—urethra—prostate cancer	0.000126	0.0128	CbGeAlD
Conjugated Estrogens—ABCC2—prostate gland—prostate cancer	0.000125	0.0128	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—prostate cancer	0.000123	0.0125	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—prostate cancer	0.000123	0.0125	CbGeAlD
Conjugated Estrogens—ESR1—prostate gland—prostate cancer	0.000114	0.0117	CbGeAlD
Conjugated Estrogens—ESR2—renal system—prostate cancer	0.000114	0.0116	CbGeAlD
Conjugated Estrogens—SLCO1B1—renal system—prostate cancer	0.000113	0.0115	CbGeAlD
Conjugated Estrogens—ABCC1—prostate gland—prostate cancer	0.00011	0.0113	CbGeAlD
Conjugated Estrogens—SLC10A1—testis—prostate cancer	0.00011	0.0112	CbGeAlD
Conjugated Estrogens—COMT—renal system—prostate cancer	0.000108	0.0111	CbGeAlD
Conjugated Estrogens—ABCC3—renal system—prostate cancer	0.000107	0.0109	CbGeAlD
Conjugated Estrogens—COMT—urethra—prostate cancer	0.000106	0.0109	CbGeAlD
Conjugated Estrogens—SLCO1C1—testis—prostate cancer	0.000103	0.0105	CbGeAlD
Conjugated Estrogens—SLCO2B1—renal system—prostate cancer	9.97e-05	0.0102	CbGeAlD
Conjugated Estrogens—CYP3A4—Doxorubicin—prostate cancer	9.89e-05	0.000788	CbGbCtD
Conjugated Estrogens—ABCC1—seminal vesicle—prostate cancer	9.34e-05	0.00954	CbGeAlD
Conjugated Estrogens—SLCO1A2—renal system—prostate cancer	9.18e-05	0.00937	CbGeAlD
Conjugated Estrogens—ABCG2—prostate gland—prostate cancer	9.15e-05	0.00934	CbGeAlD
Conjugated Estrogens—SLCO3A1—testis—prostate cancer	9.09e-05	0.00928	CbGeAlD
Conjugated Estrogens—ABCC4—renal system—prostate cancer	8.83e-05	0.00901	CbGeAlD
Conjugated Estrogens—SLC22A8—renal system—prostate cancer	8.76e-05	0.00894	CbGeAlD
Conjugated Estrogens—ABCC2—renal system—prostate cancer	8.55e-05	0.00873	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—prostate cancer	8.39e-05	0.00856	CbGeAlD
Conjugated Estrogens—SLCO4A1—testis—prostate cancer	8.28e-05	0.00845	CbGeAlD
Conjugated Estrogens—COMT—bone marrow—prostate cancer	8.19e-05	0.00836	CbGeAlD
Conjugated Estrogens—ESR1—renal system—prostate cancer	7.78e-05	0.00794	CbGeAlD
Conjugated Estrogens—ABCG2—seminal vesicle—prostate cancer	7.74e-05	0.0079	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—prostate cancer	7.49e-05	0.00765	CbGeAlD
Conjugated Estrogens—ABCC1—urethra—prostate cancer	7.4e-05	0.00755	CbGeAlD
Conjugated Estrogens—ESR2—testis—prostate cancer	7.34e-05	0.0075	CbGeAlD
Conjugated Estrogens—COMT—testis—prostate cancer	7e-05	0.00715	CbGeAlD
Conjugated Estrogens—ABCC3—testis—prostate cancer	6.91e-05	0.00706	CbGeAlD
Conjugated Estrogens—ABCC4—bone marrow—prostate cancer	6.68e-05	0.00682	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—prostate cancer	6.59e-05	0.00673	CbGeAlD
Conjugated Estrogens—SLCO2B1—testis—prostate cancer	6.44e-05	0.00658	CbGeAlD
Conjugated Estrogens—ABCG2—urethra—prostate cancer	6.12e-05	0.00625	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—prostate cancer	6e-05	0.00613	CbGeAlD
Conjugated Estrogens—CYP1A2—renal system—prostate cancer	6e-05	0.00612	CbGeAlD
Conjugated Estrogens—SLCO1A2—testis—prostate cancer	5.93e-05	0.00605	CbGeAlD
Conjugated Estrogens—ABCC4—testis—prostate cancer	5.71e-05	0.00583	CbGeAlD
Conjugated Estrogens—ABCC2—testis—prostate cancer	5.52e-05	0.00564	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—prostate cancer	5.32e-05	0.00543	CbGeAlD
Conjugated Estrogens—COMT—lymph node—prostate cancer	5.08e-05	0.00518	CbGeAlD
Conjugated Estrogens—ESR1—testis—prostate cancer	5.03e-05	0.00513	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—prostate cancer	5.01e-05	0.00512	CbGeAlD
Conjugated Estrogens—ABCC1—testis—prostate cancer	4.87e-05	0.00497	CbGeAlD
Conjugated Estrogens—ABCG2—bone marrow—prostate cancer	4.71e-05	0.00481	CbGeAlD
Conjugated Estrogens—Equilin—SHBG—prostate cancer	4.71e-05	0.0446	CrCbGaD
Conjugated Estrogens—SLCO2B1—lymph node—prostate cancer	4.67e-05	0.00477	CbGeAlD
Conjugated Estrogens—ABCB1—prostate gland—prostate cancer	4.51e-05	0.0046	CbGeAlD
Conjugated Estrogens—Ethinyl Estradiol—AOX1—prostate cancer	4.35e-05	0.0413	CrCbGaD
Conjugated Estrogens—CYP3A4—renal system—prostate cancer	4.34e-05	0.00443	CbGeAlD
Conjugated Estrogens—ABCC4—lymph node—prostate cancer	4.14e-05	0.00422	CbGeAlD
Conjugated Estrogens—ABCG2—testis—prostate cancer	4.03e-05	0.00411	CbGeAlD
Conjugated Estrogens—ABCC2—lymph node—prostate cancer	4e-05	0.00409	CbGeAlD
Conjugated Estrogens—ABCB1—seminal vesicle—prostate cancer	3.81e-05	0.00389	CbGeAlD
Conjugated Estrogens—ESR1—lymph node—prostate cancer	3.65e-05	0.00372	CbGeAlD
Conjugated Estrogens—ABCC1—lymph node—prostate cancer	3.53e-05	0.0036	CbGeAlD
Conjugated Estrogens—ABCB1—epithelium—prostate cancer	3.31e-05	0.00338	CbGeAlD
Conjugated Estrogens—Estriol—ESR2—prostate cancer	3.23e-05	0.0307	CrCbGaD
Conjugated Estrogens—ABCB1—renal system—prostate cancer	3.07e-05	0.00314	CbGeAlD
Conjugated Estrogens—ABCB1—urethra—prostate cancer	3.02e-05	0.00308	CbGeAlD
Conjugated Estrogens—Quinestrol—ESR1—prostate cancer	3.01e-05	0.0286	CrCbGaD
Conjugated Estrogens—Estramustine—ESR2—prostate cancer	3.01e-05	0.0285	CrCbGaD
Conjugated Estrogens—Estriol—SHBG—prostate cancer	2.95e-05	0.028	CrCbGaD
Conjugated Estrogens—ABCG2—lymph node—prostate cancer	2.92e-05	0.00298	CbGeAlD
Conjugated Estrogens—Estradiol—AOX1—prostate cancer	2.88e-05	0.0273	CrCbGaD
Conjugated Estrogens—Exemestane—CYP19A1—prostate cancer	2.78e-05	0.0264	CrCbGaD
Conjugated Estrogens—Estropipate—ESR2—prostate cancer	2.47e-05	0.0235	CrCbGaD
Conjugated Estrogens—ABCB1—bone marrow—prostate cancer	2.32e-05	0.00237	CbGeAlD
Conjugated Estrogens—Mestranol—ESR1—prostate cancer	2.28e-05	0.0217	CrCbGaD
Conjugated Estrogens—Estropipate—SHBG—prostate cancer	2.26e-05	0.0214	CrCbGaD
Conjugated Estrogens—Estropipate—SLC22A1—prostate cancer	2.23e-05	0.0211	CrCbGaD
Conjugated Estrogens—Estriol—ESR1—prostate cancer	1.99e-05	0.0189	CrCbGaD
Conjugated Estrogens—ABCB1—testis—prostate cancer	1.99e-05	0.00203	CbGeAlD
Conjugated Estrogens—Estramustine—ESR1—prostate cancer	1.85e-05	0.0176	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ESR2—prostate cancer	1.77e-05	0.0168	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—SHBG—prostate cancer	1.61e-05	0.0153	CrCbGaD
Conjugated Estrogens—Estrone—ESR2—prostate cancer	1.54e-05	0.0146	CrCbGaD
Conjugated Estrogens—Estropipate—ESR1—prostate cancer	1.52e-05	0.0145	CrCbGaD
Conjugated Estrogens—Estradiol—SLC22A3—prostate cancer	1.46e-05	0.0139	CrCbGaD
Conjugated Estrogens—ABCB1—lymph node—prostate cancer	1.44e-05	0.00147	CbGeAlD
Conjugated Estrogens—Estrone—SHBG—prostate cancer	1.4e-05	0.0133	CrCbGaD
Conjugated Estrogens—Estrone—CYP1B1—prostate cancer	1.4e-05	0.0133	CrCbGaD
Conjugated Estrogens—Exemestane—CYP3A4—prostate cancer	1.31e-05	0.0124	CrCbGaD
Conjugated Estrogens—Estradiol—ESR2—prostate cancer	1.17e-05	0.0111	CrCbGaD
Conjugated Estrogens—Estrone—CYP3A5—prostate cancer	1.12e-05	0.0106	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ESR1—prostate cancer	1.09e-05	0.0103	CrCbGaD
Conjugated Estrogens—Estradiol—CYP1B1—prostate cancer	1.06e-05	0.0101	CrCbGaD
Conjugated Estrogens—Estradiol—SHBG—prostate cancer	1.06e-05	0.0101	CrCbGaD
Conjugated Estrogens—Estradiol—SLC22A1—prostate cancer	1.05e-05	0.00996	CrCbGaD
Conjugated Estrogens—Estrone—ESR1—prostate cancer	9.48e-06	0.009	CrCbGaD
Conjugated Estrogens—Estramustine—CYP3A4—prostate cancer	9.45e-06	0.00897	CrCbGaD
Conjugated Estrogens—Estradiol—AR—prostate cancer	9.33e-06	0.00885	CrCbGaD
Conjugated Estrogens—Estradiol—CYP3A5—prostate cancer	8.47e-06	0.00804	CrCbGaD
Conjugated Estrogens—Estropipate—CYP3A4—prostate cancer	7.78e-06	0.00738	CrCbGaD
Conjugated Estrogens—Estrone—CYP2E1—prostate cancer	7.69e-06	0.00729	CrCbGaD
Conjugated Estrogens—Estrone—CYP1A1—prostate cancer	7.58e-06	0.00719	CrCbGaD
Conjugated Estrogens—Estradiol—ESR1—prostate cancer	7.19e-06	0.00682	CrCbGaD
Conjugated Estrogens—Estradiol—CYP2C19—prostate cancer	5.77e-06	0.00547	CrCbGaD
Conjugated Estrogens—Estradiol—CYP1A1—prostate cancer	5.75e-06	0.00545	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—CYP3A4—prostate cancer	5.56e-06	0.00527	CrCbGaD
Conjugated Estrogens—Estrone—CYP3A4—prostate cancer	4.84e-06	0.00459	CrCbGaD
Conjugated Estrogens—Body temperature increased—Etoposide—prostate cancer	3.71e-06	8.97e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Etoposide—prostate cancer	3.71e-06	8.97e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Capecitabine—prostate cancer	3.7e-06	8.96e-05	CcSEcCtD
Conjugated Estrogens—Vertigo—Prednisone—prostate cancer	3.7e-06	8.96e-05	CcSEcCtD
Conjugated Estrogens—Syncope—Prednisone—prostate cancer	3.69e-06	8.94e-05	CcSEcCtD
Conjugated Estrogens—Tachycardia—Capecitabine—prostate cancer	3.68e-06	8.91e-05	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Epirubicin—prostate cancer	3.68e-06	8.91e-05	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Epirubicin—prostate cancer	3.67e-06	8.89e-05	CcSEcCtD
Conjugated Estrogens—Estradiol—CYP3A4—prostate cancer	3.67e-06	0.00348	CrCbGaD
Conjugated Estrogens—Skin disorder—Capecitabine—prostate cancer	3.66e-06	8.87e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Capecitabine—prostate cancer	3.65e-06	8.83e-05	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Epirubicin—prostate cancer	3.64e-06	8.82e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Docetaxel—prostate cancer	3.64e-06	8.82e-05	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Prednisone—prostate cancer	3.62e-06	8.76e-05	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—prostate cancer	3.61e-06	8.73e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Capecitabine—prostate cancer	3.6e-06	8.71e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Estradiol—prostate cancer	3.59e-06	8.7e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Mitoxantrone—prostate cancer	3.58e-06	8.68e-05	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—prostate cancer	3.58e-06	8.66e-05	CcSEcCtD
Conjugated Estrogens—Convulsion—Prednisone—prostate cancer	3.57e-06	8.64e-05	CcSEcCtD
Conjugated Estrogens—Visual impairment—Epirubicin—prostate cancer	3.56e-06	8.63e-05	CcSEcCtD
Conjugated Estrogens—Rash—Mitoxantrone—prostate cancer	3.55e-06	8.61e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Mitoxantrone—prostate cancer	3.55e-06	8.6e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.55e-06	8.6e-05	CcSEcCtD
Conjugated Estrogens—Headache—Mitoxantrone—prostate cancer	3.53e-06	8.55e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Capecitabine—prostate cancer	3.52e-06	8.54e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Docetaxel—prostate cancer	3.52e-06	8.53e-05	CcSEcCtD
Conjugated Estrogens—Arthralgia—Prednisone—prostate cancer	3.51e-06	8.49e-05	CcSEcCtD
Conjugated Estrogens—Myalgia—Prednisone—prostate cancer	3.51e-06	8.49e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Docetaxel—prostate cancer	3.5e-06	8.47e-05	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—prostate cancer	3.5e-06	8.47e-05	CcSEcCtD
Conjugated Estrogens—Anxiety—Prednisone—prostate cancer	3.49e-06	8.46e-05	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.48e-06	8.43e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Docetaxel—prostate cancer	3.47e-06	8.41e-05	CcSEcCtD
Conjugated Estrogens—Somnolence—Docetaxel—prostate cancer	3.46e-06	8.39e-05	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—prostate cancer	3.46e-06	8.37e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Etoposide—prostate cancer	3.45e-06	8.36e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.44e-06	8.32e-05	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—prostate cancer	3.43e-06	8.31e-05	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—prostate cancer	3.43e-06	8.31e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Docetaxel—prostate cancer	3.43e-06	8.3e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Capecitabine—prostate cancer	3.41e-06	8.26e-05	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—prostate cancer	3.41e-06	8.25e-05	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—prostate cancer	3.4e-06	8.23e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Capecitabine—prostate cancer	3.39e-06	8.2e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Docetaxel—prostate cancer	3.39e-06	8.2e-05	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—prostate cancer	3.37e-06	8.16e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Docetaxel—prostate cancer	3.36e-06	8.14e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Etoposide—prostate cancer	3.36e-06	8.14e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Capecitabine—prostate cancer	3.36e-06	8.14e-05	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Prednisone—prostate cancer	3.36e-06	8.14e-05	CcSEcCtD
Conjugated Estrogens—Oedema—Prednisone—prostate cancer	3.36e-06	8.14e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Docetaxel—prostate cancer	3.36e-06	8.13e-05	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—prostate cancer	3.36e-06	8.13e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Mitoxantrone—prostate cancer	3.35e-06	8.11e-05	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—prostate cancer	3.34e-06	8.09e-05	CcSEcCtD
Conjugated Estrogens—Infection—Prednisone—prostate cancer	3.34e-06	8.08e-05	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—prostate cancer	3.33e-06	8.07e-05	CcSEcCtD
Conjugated Estrogens—Pain—Docetaxel—prostate cancer	3.33e-06	8.07e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Docetaxel—prostate cancer	3.33e-06	8.07e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Capecitabine—prostate cancer	3.32e-06	8.04e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Etoposide—prostate cancer	3.32e-06	8.03e-05	CcSEcCtD
Conjugated Estrogens—Shock—Prednisone—prostate cancer	3.31e-06	8e-05	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Epirubicin—prostate cancer	3.3e-06	8e-05	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—prostate cancer	3.3e-06	7.99e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Prednisone—prostate cancer	3.3e-06	7.98e-05	CcSEcCtD
Conjugated Estrogens—Tachycardia—Prednisone—prostate cancer	3.28e-06	7.94e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Capecitabine—prostate cancer	3.28e-06	7.94e-05	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—prostate cancer	3.27e-06	7.91e-05	CcSEcCtD
Conjugated Estrogens—Skin disorder—Prednisone—prostate cancer	3.26e-06	7.9e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Capecitabine—prostate cancer	3.26e-06	7.89e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Capecitabine—prostate cancer	3.25e-06	7.88e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Prednisone—prostate cancer	3.25e-06	7.87e-05	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—prostate cancer	3.24e-06	7.85e-05	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—prostate cancer	3.24e-06	7.84e-05	CcSEcCtD
Conjugated Estrogens—Pain—Capecitabine—prostate cancer	3.23e-06	7.81e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Capecitabine—prostate cancer	3.23e-06	7.81e-05	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—prostate cancer	3.22e-06	7.8e-05	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—prostate cancer	3.22e-06	7.8e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Etoposide—prostate cancer	3.21e-06	7.77e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Prednisone—prostate cancer	3.2e-06	7.76e-05	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—prostate cancer	3.2e-06	7.74e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Docetaxel—prostate cancer	3.19e-06	7.71e-05	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—prostate cancer	3.18e-06	7.69e-05	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—prostate cancer	3.17e-06	7.68e-05	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—prostate cancer	3.16e-06	7.65e-05	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—prostate cancer	3.15e-06	7.64e-05	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—prostate cancer	3.13e-06	7.57e-05	CcSEcCtD
Conjugated Estrogens—Back pain—Epirubicin—prostate cancer	3.11e-06	7.54e-05	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—prostate cancer	3.11e-06	7.52e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Etoposide—prostate cancer	3.1e-06	7.51e-05	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—prostate cancer	3.1e-06	7.5e-05	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—prostate cancer	3.09e-06	7.49e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Capecitabine—prostate cancer	3.08e-06	7.47e-05	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—prostate cancer	3.08e-06	7.47e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Docetaxel—prostate cancer	3.08e-06	7.46e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Docetaxel—prostate cancer	3.08e-06	7.46e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Prednisone—prostate cancer	3.06e-06	7.41e-05	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—prostate cancer	3.06e-06	7.4e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Prednisone—prostate cancer	3.04e-06	7.36e-05	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—prostate cancer	3.03e-06	7.35e-05	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—prostate cancer	3.02e-06	7.32e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Prednisone—prostate cancer	3.02e-06	7.31e-05	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—prostate cancer	3e-06	7.26e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Capecitabine—prostate cancer	3e-06	7.26e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Capecitabine—prostate cancer	2.98e-06	7.22e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Capecitabine—prostate cancer	2.98e-06	7.22e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Etoposide—prostate cancer	2.98e-06	7.22e-05	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—prostate cancer	2.98e-06	7.21e-05	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—prostate cancer	2.98e-06	7.21e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Prednisone—prostate cancer	2.96e-06	7.16e-05	CcSEcCtD
Conjugated Estrogens—Rash—Etoposide—prostate cancer	2.96e-06	7.16e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Etoposide—prostate cancer	2.95e-06	7.15e-05	CcSEcCtD
Conjugated Estrogens—Headache—Etoposide—prostate cancer	2.94e-06	7.11e-05	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—prostate cancer	2.94e-06	7.11e-05	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—prostate cancer	2.92e-06	7.08e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Prednisone—prostate cancer	2.92e-06	7.07e-05	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Doxorubicin—prostate cancer	2.92e-06	7.06e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Prednisone—prostate cancer	2.9e-06	7.01e-05	CcSEcCtD
Conjugated Estrogens—Nervousness—Doxorubicin—prostate cancer	2.89e-06	7.01e-05	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—prostate cancer	2.89e-06	7.01e-05	CcSEcCtD
Conjugated Estrogens—Syncope—Epirubicin—prostate cancer	2.89e-06	6.99e-05	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—prostate cancer	2.88e-06	6.98e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Prednisone—prostate cancer	2.87e-06	6.96e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Docetaxel—prostate cancer	2.87e-06	6.95e-05	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—prostate cancer	2.86e-06	6.94e-05	CcSEcCtD
Conjugated Estrogens—Palpitations—Epirubicin—prostate cancer	2.85e-06	6.89e-05	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Epirubicin—prostate cancer	2.83e-06	6.85e-05	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—prostate cancer	2.81e-06	6.8e-05	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—prostate cancer	2.81e-06	6.8e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Docetaxel—prostate cancer	2.8e-06	6.77e-05	CcSEcCtD
Conjugated Estrogens—Convulsion—Epirubicin—prostate cancer	2.79e-06	6.76e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Etoposide—prostate cancer	2.78e-06	6.74e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Capecitabine—prostate cancer	2.78e-06	6.73e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Docetaxel—prostate cancer	2.76e-06	6.67e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Prednisone—prostate cancer	2.75e-06	6.65e-05	CcSEcCtD
Conjugated Estrogens—Chest pain—Epirubicin—prostate cancer	2.74e-06	6.64e-05	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—prostate cancer	2.74e-06	6.64e-05	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—prostate cancer	2.74e-06	6.64e-05	CcSEcCtD
Conjugated Estrogens—Anxiety—Epirubicin—prostate cancer	2.73e-06	6.62e-05	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.72e-06	6.59e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Capecitabine—prostate cancer	2.71e-06	6.55e-05	CcSEcCtD
Conjugated Estrogens—Vertigo—Doxorubicin—prostate cancer	2.68e-06	6.48e-05	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—prostate cancer	2.67e-06	6.47e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Prednisone—prostate cancer	2.67e-06	6.46e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Capecitabine—prostate cancer	2.67e-06	6.46e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Docetaxel—prostate cancer	2.67e-06	6.45e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Prednisone—prostate cancer	2.66e-06	6.43e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Prednisone—prostate cancer	2.66e-06	6.43e-05	CcSEcCtD
Conjugated Estrogens—Palpitations—Doxorubicin—prostate cancer	2.63e-06	6.38e-05	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—prostate cancer	2.63e-06	6.36e-05	CcSEcCtD
Conjugated Estrogens—Oedema—Epirubicin—prostate cancer	2.63e-06	6.36e-05	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—prostate cancer	2.62e-06	6.34e-05	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—prostate cancer	2.61e-06	6.32e-05	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—prostate cancer	2.6e-06	6.3e-05	CcSEcCtD
Conjugated Estrogens—Shock—Epirubicin—prostate cancer	2.59e-06	6.26e-05	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—prostate cancer	2.58e-06	6.25e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Capecitabine—prostate cancer	2.58e-06	6.25e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—prostate cancer	2.58e-06	6.24e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Docetaxel—prostate cancer	2.58e-06	6.24e-05	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—prostate cancer	2.56e-06	6.21e-05	CcSEcCtD
Conjugated Estrogens—Skin disorder—Epirubicin—prostate cancer	2.55e-06	6.18e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—prostate cancer	2.54e-06	6.15e-05	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—prostate cancer	2.54e-06	6.14e-05	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—prostate cancer	2.54e-06	6.14e-05	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—prostate cancer	2.54e-06	6.14e-05	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—prostate cancer	2.53e-06	6.12e-05	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.52e-06	6.1e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Epirubicin—prostate cancer	2.5e-06	6.07e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Capecitabine—prostate cancer	2.49e-06	6.04e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Docetaxel—prostate cancer	2.48e-06	6e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Prednisone—prostate cancer	2.48e-06	5.99e-05	CcSEcCtD
Conjugated Estrogens—Rash—Docetaxel—prostate cancer	2.46e-06	5.95e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Epirubicin—prostate cancer	2.46e-06	5.95e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Docetaxel—prostate cancer	2.45e-06	5.94e-05	CcSEcCtD
Conjugated Estrogens—Headache—Docetaxel—prostate cancer	2.44e-06	5.91e-05	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—prostate cancer	2.43e-06	5.89e-05	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—prostate cancer	2.43e-06	5.89e-05	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—prostate cancer	2.42e-06	5.85e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Prednisone—prostate cancer	2.41e-06	5.84e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Capecitabine—prostate cancer	2.4e-06	5.81e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.39e-06	5.8e-05	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—prostate cancer	2.39e-06	5.79e-05	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—prostate cancer	2.38e-06	5.77e-05	CcSEcCtD
Conjugated Estrogens—Rash—Capecitabine—prostate cancer	2.38e-06	5.76e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Prednisone—prostate cancer	2.38e-06	5.76e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Epirubicin—prostate cancer	2.38e-06	5.76e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Capecitabine—prostate cancer	2.38e-06	5.75e-05	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—prostate cancer	2.37e-06	5.75e-05	CcSEcCtD
Conjugated Estrogens—Headache—Capecitabine—prostate cancer	2.36e-06	5.72e-05	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—prostate cancer	2.36e-06	5.72e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—prostate cancer	2.36e-06	5.71e-05	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—prostate cancer	2.35e-06	5.69e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—prostate cancer	2.34e-06	5.67e-05	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—prostate cancer	2.34e-06	5.66e-05	CcSEcCtD
Conjugated Estrogens—Anorexia—Doxorubicin—prostate cancer	2.32e-06	5.61e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Docetaxel—prostate cancer	2.31e-06	5.6e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—prostate cancer	2.31e-06	5.6e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Prednisone—prostate cancer	2.3e-06	5.57e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Epirubicin—prostate cancer	2.28e-06	5.53e-05	CcSEcCtD
Conjugated Estrogens—Hypotension—Doxorubicin—prostate cancer	2.27e-06	5.5e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—prostate cancer	2.27e-06	5.49e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—prostate cancer	2.27e-06	5.49e-05	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—prostate cancer	2.25e-06	5.44e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Epirubicin—prostate cancer	2.25e-06	5.44e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Capecitabine—prostate cancer	2.24e-06	5.43e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Prednisone—prostate cancer	2.22e-06	5.38e-05	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.22e-06	5.36e-05	CcSEcCtD
Conjugated Estrogens—Insomnia—Doxorubicin—prostate cancer	2.2e-06	5.33e-05	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Doxorubicin—prostate cancer	2.18e-06	5.29e-05	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—prostate cancer	2.17e-06	5.25e-05	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—prostate cancer	2.16e-06	5.23e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—prostate cancer	2.15e-06	5.2e-05	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—prostate cancer	2.14e-06	5.18e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Prednisone—prostate cancer	2.14e-06	5.17e-05	CcSEcCtD
Conjugated Estrogens—Rash—Prednisone—prostate cancer	2.12e-06	5.13e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Prednisone—prostate cancer	2.12e-06	5.13e-05	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—prostate cancer	2.11e-06	5.12e-05	CcSEcCtD
Conjugated Estrogens—Headache—Prednisone—prostate cancer	2.1e-06	5.1e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.1e-06	5.08e-05	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—prostate cancer	2.1e-06	5.08e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Epirubicin—prostate cancer	2.09e-06	5.06e-05	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—prostate cancer	2.08e-06	5.03e-05	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—prostate cancer	2.08e-06	5.03e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—prostate cancer	2.08e-06	5.03e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—prostate cancer	2.08e-06	5.03e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Prednisone—prostate cancer	2e-06	4.83e-05	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—prostate cancer	1.99e-06	4.81e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Epirubicin—prostate cancer	1.94e-06	4.69e-05	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—prostate cancer	1.93e-06	4.68e-05	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—prostate cancer	1.92e-06	4.65e-05	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—prostate cancer	1.92e-06	4.65e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Epirubicin—prostate cancer	1.89e-06	4.57e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Epirubicin—prostate cancer	1.86e-06	4.5e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Epirubicin—prostate cancer	1.8e-06	4.35e-05	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—prostate cancer	1.79e-06	4.34e-05	CcSEcCtD
Conjugated Estrogens—Asthenia—Doxorubicin—prostate cancer	1.74e-06	4.22e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Epirubicin—prostate cancer	1.74e-06	4.21e-05	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—prostate cancer	1.72e-06	4.17e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Epirubicin—prostate cancer	1.67e-06	4.05e-05	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—prostate cancer	1.66e-06	4.03e-05	CcSEcCtD
Conjugated Estrogens—Rash—Epirubicin—prostate cancer	1.66e-06	4.01e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—prostate cancer	1.66e-06	4.01e-05	CcSEcCtD
Conjugated Estrogens—Headache—Epirubicin—prostate cancer	1.65e-06	3.99e-05	CcSEcCtD
Conjugated Estrogens—Dizziness—Doxorubicin—prostate cancer	1.61e-06	3.89e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Epirubicin—prostate cancer	1.56e-06	3.78e-05	CcSEcCtD
Conjugated Estrogens—Vomiting—Doxorubicin—prostate cancer	1.55e-06	3.74e-05	CcSEcCtD
Conjugated Estrogens—Rash—Doxorubicin—prostate cancer	1.53e-06	3.71e-05	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—prostate cancer	1.53e-06	3.71e-05	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—prostate cancer	1.52e-06	3.69e-05	CcSEcCtD
Conjugated Estrogens—Nausea—Doxorubicin—prostate cancer	1.44e-06	3.5e-05	CcSEcCtD
Conjugated Estrogens—ABCC1—Disease—PTGS2—prostate cancer	3.58e-07	1.73e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNG5—prostate cancer	3.56e-07	1.72e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—INS—prostate cancer	3.55e-07	1.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.54e-07	1.71e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.54e-07	1.71e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—EP300—prostate cancer	3.53e-07	1.7e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—prostate cancer	3.53e-07	1.7e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CREBBP—prostate cancer	3.48e-07	1.68e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CG—prostate cancer	3.48e-07	1.68e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CD—prostate cancer	3.47e-07	1.68e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—prostate cancer	3.46e-07	1.67e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA3—prostate cancer	3.43e-07	1.65e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC5A5—prostate cancer	3.42e-07	1.65e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—prostate cancer	3.4e-07	1.64e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA4—prostate cancer	3.4e-07	1.64e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.4e-07	1.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1B—prostate cancer	3.39e-07	1.64e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HIF1A—prostate cancer	3.37e-07	1.63e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.37e-07	1.63e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CB—prostate cancer	3.36e-07	1.62e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2E1—prostate cancer	3.34e-07	1.61e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—prostate cancer	3.34e-07	1.61e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—prostate cancer	3.33e-07	1.61e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA2—prostate cancer	3.31e-07	1.6e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NQO1—prostate cancer	3.3e-07	1.59e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CD—prostate cancer	3.3e-07	1.59e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—LEP—prostate cancer	3.29e-07	1.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—INS—prostate cancer	3.29e-07	1.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NOS3—prostate cancer	3.28e-07	1.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HPGDS—prostate cancer	3.27e-07	1.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.27e-07	1.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCG5—prostate cancer	3.27e-07	1.58e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CAV1—prostate cancer	3.26e-07	1.57e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TH—prostate cancer	3.25e-07	1.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.25e-07	1.57e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KDR—prostate cancer	3.22e-07	1.56e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CREBBP—prostate cancer	3.22e-07	1.56e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP3A4—prostate cancer	3.22e-07	1.55e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CTNNB1—prostate cancer	3.2e-07	1.55e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—prostate cancer	3.19e-07	1.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTA1—prostate cancer	3.19e-07	1.54e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—EP300—prostate cancer	3.18e-07	1.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTT1—prostate cancer	3.17e-07	1.53e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ACHE—prostate cancer	3.17e-07	1.53e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1B1—prostate cancer	3.17e-07	1.53e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.16e-07	1.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTO1—prostate cancer	3.16e-07	1.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NAT2—prostate cancer	3.16e-07	1.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.14e-07	1.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—prostate cancer	3.13e-07	1.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.12e-07	1.51e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—prostate cancer	3.12e-07	1.51e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NOS3—prostate cancer	3.12e-07	1.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BAD—prostate cancer	3.07e-07	1.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GGT1—prostate cancer	3.07e-07	1.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CD—prostate cancer	3.06e-07	1.47e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.05e-07	1.47e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PRKACB—prostate cancer	3.03e-07	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CB—prostate cancer	3.03e-07	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PLCB2—prostate cancer	3.03e-07	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.03e-07	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—LRP2—prostate cancer	3.03e-07	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NCOA1—prostate cancer	3.02e-07	1.46e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP17A1—prostate cancer	3e-07	1.45e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—prostate cancer	3e-07	1.45e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EP300—prostate cancer	2.98e-07	1.44e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP19A1—prostate cancer	2.98e-07	1.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APC—prostate cancer	2.97e-07	1.43e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CG—prostate cancer	2.97e-07	1.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—P4HB—prostate cancer	2.97e-07	1.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.96e-07	1.43e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGF—prostate cancer	2.94e-07	1.42e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IRS1—prostate cancer	2.94e-07	1.42e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—prostate cancer	2.91e-07	1.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SRC—prostate cancer	2.9e-07	1.4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.89e-07	1.39e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NOS3—prostate cancer	2.89e-07	1.39e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.88e-07	1.39e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—RXRA—prostate cancer	2.87e-07	1.39e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA2—prostate cancer	2.86e-07	1.38e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.85e-07	1.38e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GSK3B—prostate cancer	2.85e-07	1.38e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.81e-07	1.36e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—INS—prostate cancer	2.81e-07	1.36e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—prostate cancer	2.79e-07	1.35e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—EP300—prostate cancer	2.77e-07	1.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MED12—prostate cancer	2.77e-07	1.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—COMT—prostate cancer	2.77e-07	1.34e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTP1—prostate cancer	2.75e-07	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CREBBP—prostate cancer	2.75e-07	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNG5—prostate cancer	2.75e-07	1.33e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.73e-07	1.32e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IGF1—prostate cancer	2.72e-07	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ITPR1—prostate cancer	2.71e-07	1.31e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.67e-07	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CB—prostate cancer	2.66e-07	1.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA3—prostate cancer	2.65e-07	1.28e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—prostate cancer	2.64e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NQO1—prostate cancer	2.64e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAP2K1—prostate cancer	2.63e-07	1.27e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—prostate cancer	2.62e-07	1.26e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CD—prostate cancer	2.61e-07	1.26e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—prostate cancer	2.61e-07	1.26e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—prostate cancer	2.61e-07	1.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TH—prostate cancer	2.6e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—prostate cancer	2.6e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TGFB1—prostate cancer	2.59e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SERPINE1—prostate cancer	2.58e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.58e-07	1.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.57e-07	1.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMS—prostate cancer	2.56e-07	1.24e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.56e-07	1.23e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—prostate cancer	2.54e-07	1.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTM1—prostate cancer	2.53e-07	1.22e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.53e-07	1.22e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HPGDS—prostate cancer	2.52e-07	1.22e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—prostate cancer	2.51e-07	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.51e-07	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGF2—prostate cancer	2.5e-07	1.21e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—EP300—prostate cancer	2.49e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—prostate cancer	2.49e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—LPL—prostate cancer	2.48e-07	1.2e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NOS3—prostate cancer	2.47e-07	1.19e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTT1—prostate cancer	2.45e-07	1.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ACHE—prostate cancer	2.45e-07	1.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GGT1—prostate cancer	2.45e-07	1.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.42e-07	1.17e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOA1—prostate cancer	2.41e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1A1—prostate cancer	2.4e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—prostate cancer	2.4e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JAK2—prostate cancer	2.4e-07	1.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ERCC2—prostate cancer	2.38e-07	1.15e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.38e-07	1.15e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—EP300—prostate cancer	2.37e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—prostate cancer	2.36e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.35e-07	1.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PRKACB—prostate cancer	2.34e-07	1.13e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—prostate cancer	2.34e-07	1.13e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.32e-07	1.12e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—prostate cancer	2.31e-07	1.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—prostate cancer	2.3e-07	1.11e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—RXRA—prostate cancer	2.29e-07	1.11e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CB—prostate cancer	2.28e-07	1.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—MTHFR—prostate cancer	2.24e-07	1.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.23e-07	1.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—COMT—prostate cancer	2.21e-07	1.07e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA2—prostate cancer	2.21e-07	1.07e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—prostate cancer	2.2e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTP1—prostate cancer	2.2e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—EP300—prostate cancer	2.2e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPARA—prostate cancer	2.19e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—prostate cancer	2.19e-07	1.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ITPR1—prostate cancer	2.16e-07	1.04e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1B—prostate cancer	2.14e-07	1.03e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—prostate cancer	2.13e-07	1.03e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.13e-07	1.03e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.11e-07	1.02e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—prostate cancer	2.09e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—prostate cancer	2.09e-07	1.01e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAV1—prostate cancer	2.06e-07	9.96e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.06e-07	9.93e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—prostate cancer	2.05e-07	9.89e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMS—prostate cancer	2.04e-07	9.86e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—prostate cancer	2.04e-07	9.83e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NQO1—prostate cancer	2.03e-07	9.82e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTM1—prostate cancer	2.02e-07	9.75e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CTNNB1—prostate cancer	2.02e-07	9.74e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TH—prostate cancer	2.01e-07	9.68e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—LPL—prostate cancer	1.98e-07	9.57e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—prostate cancer	1.98e-07	9.54e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—prostate cancer	1.97e-07	9.51e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—prostate cancer	1.97e-07	9.49e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—prostate cancer	1.95e-07	9.41e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.95e-07	9.41e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—prostate cancer	1.92e-07	9.28e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.92e-07	9.24e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ERCC2—prostate cancer	1.9e-07	9.17e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GGT1—prostate cancer	1.89e-07	9.12e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CG—prostate cancer	1.88e-07	9.07e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EP300—prostate cancer	1.88e-07	9.05e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOA1—prostate cancer	1.86e-07	8.98e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—prostate cancer	1.85e-07	8.9e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.83e-07	8.85e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SRC—prostate cancer	1.82e-07	8.8e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—prostate cancer	1.8e-07	8.69e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—MTHFR—prostate cancer	1.79e-07	8.62e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—INS—prostate cancer	1.78e-07	8.58e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—prostate cancer	1.78e-07	8.57e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—RXRA—prostate cancer	1.77e-07	8.54e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—prostate cancer	1.76e-07	8.49e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.75e-07	8.46e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPARA—prostate cancer	1.75e-07	8.45e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—prostate cancer	1.74e-07	8.41e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CREBBP—prostate cancer	1.74e-07	8.41e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—COMT—prostate cancer	1.71e-07	8.23e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTP1—prostate cancer	1.7e-07	8.19e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—prostate cancer	1.68e-07	8.08e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ITPR1—prostate cancer	1.67e-07	8.06e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CD—prostate cancer	1.65e-07	7.97e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAV1—prostate cancer	1.65e-07	7.95e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—prostate cancer	1.63e-07	7.89e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TGFB1—prostate cancer	1.63e-07	7.87e-06	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—prostate cancer	1.62e-07	7.83e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—prostate cancer	1.6e-07	7.71e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMS—prostate cancer	1.58e-07	7.61e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.57e-07	7.59e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NOS3—prostate cancer	1.56e-07	7.53e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTM1—prostate cancer	1.56e-07	7.52e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—LPL—prostate cancer	1.53e-07	7.39e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—prostate cancer	1.51e-07	7.29e-06	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—prostate cancer	1.51e-07	7.27e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.5e-07	7.24e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.48e-07	7.13e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ERCC2—prostate cancer	1.47e-07	7.07e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CB—prostate cancer	1.44e-07	6.95e-06	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—prostate cancer	1.43e-07	6.91e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—prostate cancer	1.43e-07	6.88e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—INS—prostate cancer	1.42e-07	6.85e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CREBBP—prostate cancer	1.39e-07	6.71e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—prostate cancer	1.39e-07	6.69e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MTHFR—prostate cancer	1.38e-07	6.65e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPARA—prostate cancer	1.35e-07	6.52e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—prostate cancer	1.34e-07	6.48e-06	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—prostate cancer	1.33e-07	6.4e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.32e-07	6.36e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAV1—prostate cancer	1.27e-07	6.13e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NOS3—prostate cancer	1.25e-07	6.01e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—prostate cancer	1.24e-07	6e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—prostate cancer	1.23e-07	5.93e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—EP300—prostate cancer	1.19e-07	5.73e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.16e-07	5.59e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.15e-07	5.55e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—prostate cancer	1.14e-07	5.5e-06	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—prostate cancer	1.13e-07	5.47e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—INS—prostate cancer	1.1e-07	5.29e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CREBBP—prostate cancer	1.07e-07	5.18e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.02e-07	4.91e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—prostate cancer	9.93e-08	4.79e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NOS3—prostate cancer	9.61e-08	4.64e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—EP300—prostate cancer	9.47e-08	4.57e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.87e-08	4.28e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—prostate cancer	8.79e-08	4.24e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—prostate cancer	8.78e-08	4.24e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—prostate cancer	7.67e-08	3.7e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—EP300—prostate cancer	7.31e-08	3.53e-06	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—prostate cancer	7.17e-08	3.46e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—prostate cancer	7.01e-08	3.38e-06	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—prostate cancer	5.73e-08	2.76e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.41e-08	2.61e-06	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—prostate cancer	4.42e-08	2.13e-06	CbGpPWpGaD
